Lack of sunlight may be to blame for winter weight gain
Can't see this email? View it online
   
  January 14, 2018  
  Pharmacy / Pharmacology  
  The latest pharmacy / pharmacology news from News Medical  
 Lack of sunlight may be to blame for winter weight gainLack of sunlight may be to blame for winter weight gain
 
We may have a new reason, in addition to vitamin D generation, to bask in a little sunshine. A breakthrough study by University of Alberta researchers has shown the fat cells that lie just beneath our skin shrink when exposed to the blue light emitted by the sun.
 
 
 Sunlight exposure may help lose weightSunlight exposure may help lose weight
 
Putting on extra kilos during winters has been blamed on holiday treats and less physical activity. Now a new study shows that less exposure to be the key to putting on the weight. A sunny vacation might help lose that extra weight say researchers at University of Alberta in Canada. The study appeared in the journal Scientific Reports.
 
   Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s diseaseSynergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease
 
Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.
 
   Passive Smoking Risks to ChildrenPassive Smoking Risks to Children
 
Passive smoking or involuntary smoking refers to the unconscious inhalation of smoke that emerges as a result of others burning cigarettes, cigars, or pipes. This inhaled smoke is also termed as known as environmental tobacco smoke (ETS) or second-hand smoke (SHS). Mostly children are affected by passive smoking at a higher rate than adults.
 
   Vanderbilt and Lundbeck collaborate to develop novel approach for treating schizophreniaVanderbilt and Lundbeck collaborate to develop novel approach for treating schizophrenia
 
Vanderbilt University has signed separate licensing and research collaboration agreements with Lundbeck, a global pharmaceutical company based in Denmark, to develop a novel approach for treating schizophrenia.
 
 Magic mushrooms substance Psilocybin on trial for treatment of depression
 
Magic mushrooms substance Psilocybin on trial for treatment of depressionThere are ongoing studies that look at the effect of hallucinogenic psychedelic substance Psilocybin or “magic mushrooms” in the treatment of depression.
 
 
 Excessive fluoride from some teas can damage bones and cause many health effects
 
Excessive fluoride from some teas can damage bones and cause many health effectsSome teas contain more fluoride than EPA allows in public water supplies, which can do skeletal damage, according to research published in Environmental Pollution, reports the New York State Coalition Opposed to Fluoridation, Inc.
 
 
 Salk scientists identify molecular target of experimental Alzheimer’s drug
 
Salk scientists identify molecular target of experimental Alzheimer’s drugThe experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.